• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.04% Nasdaq Down 1.11%

    Alimera Sciences, Inc. (ALIM)

    -NasdaqGM
    4.24 Down 0.22(4.93%) May 26, 3:59PM EDT
    Add to Portfolio
    Prev Close:4.46
    Open:4.44
    Bid:3.50 x 300
    Ask:4.45 x 400
    1y Target Est:11.00
    Beta:1.02
    Earnings Date:Aug 5 - Aug 10 (Est.)
    Day's Range:3.98 - 4.46
    52wk Range:3.98 - 6.54
    Volume:350,459
    Avg Vol (3m):148,243
    Market Cap:188.20M
    P/E (ttm):N/A
    EPS (ttm):-0.60
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ALIMDown 4.93%188.20M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):19.25
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.73
    Quarterly EPS Est (Jun-15) :-0.22
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alimera Sciences, Inc., a pharmaceutical company, engages in the research, development, and commercialization of prescription ophthalmic pharmaceuticals in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback